Captor Therapeutics Spolka Akcyjna (WSE:CTX)

WSE:CTX Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.4	10.72	39.26	75.7	71.04	117.94
Short-Term Investments	69.1	-	-	-	19.85	-
Cash & Short-Term Investments	71.5	10.72	39.26	75.7	90.89	117.94
Cash Growth	46.71%	-72.69%	-48.14%	-16.71%	-22.94%	1007.03%
Accounts Receivable	0.92	-	2.95	6.37	0.98	0.97
Other Receivables	2.35	1.22	35.3	6.2	8.7	10.73
Receivables	3.27	1.22	38.25	12.57	9.68	11.71
Prepaid Expenses	-	0.11	0.11	0.09	0.07	0.06
Other Current Assets	-	21.78	0.47	0.29	0.68	0.85
Total Current Assets	74.77	33.82	78.09	88.65	101.32	130.56
Property, Plant & Equipment	3.68	4.91	7.86	6.95	10.67	12.61
Other Intangible Assets	1	1.18	0.42	0.31	0.6	0.18
Long-Term Deferred Charges	-	-	0.99	1.17	0.18	0.18
Other Long-Term Assets	0.1	0.11	0.15	0.22	0.23	0.01
Total Assets	79.54	40.02	87.5	97.29	113	143.54

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.43	2.55	2.65	6.5	5.65	3.19
Accrued Expenses	-	0.81	8.6	9.41	1.48	2.25
Current Portion of Leases	2.12	2.06	2.75	2.53	3.72	5.24
Current Income Taxes Payable	-	1.02	1.22	0.96	1.35	0.9
Current Unearned Revenue	4.55	7.74	2.91	7.18	0.13	0.13
Other Current Liabilities	0.72	0.73	1.9	0.15	1.08	4.66
Total Current Liabilities	13.82	14.91	20.03	26.73	13.39	16.37
Long-Term Leases	0.54	1.52	2.89	1.25	3.24	2.94
Pension & Post-Retirement Benefits	0.11	0.12	0.1	0.1	0.05	0.03
Total Liabilities	14.48	16.54	23.02	28.07	16.68	19.34

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.64	0.55	0.55	0.47	0.42	0.41
Additional Paid-In Capital	304.6	240.49	240.49	208.88	170.03	170.03
Retained Earnings	-267.87	-245.11	-203.11	-164.69	-94.1	-58.21
Comprehensive Income & Other	27.71	27.54	26.54	24.56	19.98	11.97
Shareholders' Equity	65.07	23.48	64.47	69.22	96.32	124.2
Total Liabilities & Equity	79.54	40.02	87.5	97.29	113	143.54

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.66	3.58	5.64	3.78	6.95	8.18
Net Cash (Debt)	68.84	7.14	33.62	71.93	83.94	109.76
Net Cash Growth	45.58%	-78.75%	-53.26%	-14.31%	-23.53%	-
Net Cash Per Share	12.06	1.29	7.22	15.48	20.14	26.59
Filing Date Shares Outstanding	6.35	6.35	5.5	4.65	4.17	4.13
Total Common Shares Outstanding	6.35	5.53	5.5	4.65	4.17	4.13
Working Capital	60.94	18.91	58.06	61.92	87.93	114.19
Book Value Per Share	10.24	4.25	11.73	14.90	23.11	30.09
Tangible Book Value	64.07	22.3	64.06	68.91	95.72	124.02
Tangible Book Value Per Share	10.08	4.03	11.66	14.83	22.96	30.04
Buildings	-	0.15	0.16	14.94	13.84	9.77
Machinery	-	7.18	7.31	19.92	19.61	24.85

Data Source: S&P Global Market Intelligence Last updated: Sep 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 6, 2026

Data Sources Report a data error